Roche to present new pivotal data at ASH 2021 from broad and comprehensive portfolio, challenging treatment standards for people with blood disorders

Phase III POLARIX trial showed Polivy plus R-CHP was the first treatment in two decades to significantly improve outcomes in newly diagnosed diffuse large B-cell lymphoma (DLBCL) versus the standard of care1 Pivotal data on mosunetuzumab, a potential first-in-class CD20xCD3 T-cell engaging bispecific antibody, showed high response rates in relapsed or refractory follicular lymphoma (FL)2... Read more

GE Healthcare Receives FDA Clearance for First X-ray AI to Help Assess Endotracheal Tube Placement

Critical Care Suite 2.0 helps clinicians assess Endotracheal Tube (ETT) placement for intubated patients, including critical COVID-19 patients The AI suite also includes algorithms that help radiologists prioritize critical cases and automate processes to help cut average review time from up to eight hours1 CHICAGO – November 15, 2021 – GE Healthcare today announced it... Read more

Brooks Automation Reports Results of Fourth Quarter of Fiscal 2021, Ended September 30, 2021, and Announces Quarterly Cash Dividend

Brooks Automation Reports Results of Fourth Quarter of Fiscal 2021, Ended September 30, 2021, and Announces Quarterly Cash Dividend Strong Double-Digit Growth Quarter Underscores Robust Demand Environment in Life Sciences CHELMSFORD, Mass., Nov. 10, 2021 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS) today reported financial results for the fiscal quarter ended September 30, 2021. Summary of... Read more

Working Towards Ultrasensitive, Affordable Sensors for Glucose and Glyphosate

Dr. Francesco Ruffino is an Associate Professor of Experimental Physics at the University of Catania, Italy. His research is focused on the study and fabrication of metal-based nanostructures, nanomaterials and nanocomposites and on their applications in some important technological fields connected to the challenges of the human society. External content Scientific Reports High optical enhancement... Read more

BD Announces Fourth Fiscal Quarter And Full Year 2021 Results; Issues Fiscal Year 2022 Guidance

FRANKLIN LAKES, N.J., Nov. 4, 2021 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for the fourth fiscal quarter and full fiscal year ended September 30, 2021. “Our strong performance in fiscal 2021 was driven by the extraordinary efforts of our global team and demonstrates the resilience... Read more

PacBio Announces Third Quarter 2021 Financial Results

MENLO PARK, Calif., Nov. 02, 2021 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB) today announced financial results for the quarter ended September 30, 2021. Record revenue reflects 6th straight quarter of sequential growth Revenue of $34.9 million, an 83% increase compared with $19.1 million in the prior year period. Placed 44 Sequel II/IIe systems during the... Read more

PerkinElmer Announces Financial Results for the Third Quarter of 2021

Revenue of $1.17 billion; 21% reported growth; 12% organic growth GAAP EPS from continuing operations of $1.11; Adjusted EPS of $2.31 Initiates Fourth Quarter Guidance and Raises Full Year Revenue and Earnings Guidance WALTHAM, Mass.–(BUSINESS WIRE)–Nov. 2, 2021– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today reported financial... Read more

Xylem Reports Third Quarter 2021 Results

Orders growth of 22% on a reported basis, 20% organically, from strong underlying demand across segments Revenue growth 4% on a reported basis, 2% organically Net income as a percentage of revenue of 9.0%, up 600 basis points; adjusted EBITDA margin of 17.9%, down 30 basis points Reported net income of $114 million or $0.63... Read more

Bruker Reports Third Quarter 2021 Financial Results

Q3 2021 revenues of $608.9 million, up 19.1% year-over-year (yoy); organic growth of 17.8% Q3 2021 GAAP EPS of $0.57, up 63% yoy; non-GAAP EPS of $0.63, up 50% yoy Raising FY 2021 guidance significantly on strong demand for Bruker’s products and solutions BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced financial results for... Read more

PerkinElmer Releases 2021 Corporate Social Responsibility Report

Report highlights stewardship and sustainability progress and solidifies new ESG commitments WALTHAM, Mass.–(BUSINESS WIRE)–Nov. 1, 2021– PerkinElmer, Inc. (NYSE: PKI), a global leader innovating for a healthier world, today released its 2021 Corporate Social Responsibility (CSR) Report, which summarizes the latest achievements of its environmental, social and governance (ESG) program. The report titled, “Strengthening Our... Read more